SIMVASTATIN News
SIMVASTATIN currently has 2 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for SIMVASTATIN with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (20):
- atherosclerosis (99.0%)
- hyperlipidemia, familial combined, LPL related (99.0%)
- cerebral infarction (99.0%)
- obsolete susceptibility to ischemic stroke (99.0%)
- hyperlipoproteinemia (99.0%)
- homozygous familial hypercholesterolemia (99.0%)
- hypertriglyceridemia (disease) (99.0%)
- stroke disorder (99.0%)
- arteriosclerosis disorder (99.0%)
- obsolete familial combined hyperlipidemia (99.0%)
- hypoalphalipoproteinemia (99.0%)
- cerebrovascular disorder (99.0%)
- familial hypercholesterolemia (99.6%)
- brain stem infarction (99.4%)
- cholesterol-ester transfer protein deficiency (99.4%)
- hypercholesterolemia, autosomal dominant (99.4%)
- hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency (99.3%)
- HIV infectious disease (99.2%)
- ABri amyloidosis (99.1%)
- neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter (99.1%)
Related News (2)
From wrist to research: Harnessing smartwatch data for equitable cardiovascular research
2026-09-28 cardiovascular
Source: journals.plos.org
Conference MDAngle: HFSA 2026 Amyloidosis/ATTR-CM
2026-09-28 heart disease
Source: Medscape
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.